Cargando…
Metabolic regulation by the intestinal metformin-AMPK axis
AMP-activated protein kinase (AMPK) mediates the glucose-lowering effect of the antidiabetic agent metformin, but the sites of action remain unclear. In the March issue of Nature Communications, Zhang and colleagues reported that intestinal epithelium-specific AMPKα1 knockout mice fail to respond to...
Autores principales: | Zhang, Song-Yang, Lam, Tony K. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126964/ https://www.ncbi.nlm.nih.gov/pubmed/35606343 http://dx.doi.org/10.1038/s41467-022-30477-3 |
Ejemplares similares
-
Metformin attenuates diabetic renal injury via the AMPK-autophagy axis
por: Sun, Tingli, et al.
Publicado: (2021) -
AMPK/Ulk1-dependent autophagy as a key mTOR regulator in the context of cell pluripotency
por: Suvorova, Irina I., et al.
Publicado: (2019) -
Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19?
por: Dardano, Angela, et al.
Publicado: (2021) -
Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis
por: Liu, Bingli, et al.
Publicado: (2023) -
Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)